| pubmed-article:2857361 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2857361 | lifeskim:mentions | umls-concept:C0026769 | lld:lifeskim |
| pubmed-article:2857361 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:2857361 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:2857361 | lifeskim:mentions | umls-concept:C0279328 | lld:lifeskim |
| pubmed-article:2857361 | pubmed:issue | 8424 | lld:pubmed |
| pubmed-article:2857361 | pubmed:dateCreated | 1985-3-14 | lld:pubmed |
| pubmed-article:2857361 | pubmed:abstractText | In a study of 120 patients with chronic multiple sclerosis the effects of treatment with 100% oxygen at 2 atmospheres absolute for 90 min daily for a total of 20 exposures were compared with those of normal air at normal pressure for a similar length of time within the same compression chamber. No patient in either group showed any improvement on the Kurtzke disability status scale. 12 of 51 patients in the hyperbaric-oxygen group and 3 of 47 control patients improved on the Kurtzke functional systems scale on the subjective bowel/bladder parameter only. Such a degree of improvement can also be achieved with medication for urinary symptoms, but none of the patients in this study received such medication. The short-term results of this trial do not support the claims made for hyperbaric oxygen in the management of multiple sclerosis. | lld:pubmed |
| pubmed-article:2857361 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2857361 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2857361 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:2857361 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2857361 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:2857361 | pubmed:issn | 0140-6736 | lld:pubmed |
| pubmed-article:2857361 | pubmed:author | pubmed-author:BatesDD | lld:pubmed |
| pubmed-article:2857361 | pubmed:author | pubmed-author:CartlidgeN... | lld:pubmed |
| pubmed-article:2857361 | pubmed:author | pubmed-author:ShawD ADA | lld:pubmed |
| pubmed-article:2857361 | pubmed:author | pubmed-author:FrenchJ MJM | lld:pubmed |
| pubmed-article:2857361 | pubmed:author | pubmed-author:BarnesM PMP | lld:pubmed |
| pubmed-article:2857361 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2857361 | pubmed:day | 9 | lld:pubmed |
| pubmed-article:2857361 | pubmed:volume | 1 | lld:pubmed |
| pubmed-article:2857361 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2857361 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2857361 | pubmed:pagination | 297-300 | lld:pubmed |
| pubmed-article:2857361 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:2857361 | pubmed:meshHeading | pubmed-meshheading:2857361-... | lld:pubmed |
| pubmed-article:2857361 | pubmed:meshHeading | pubmed-meshheading:2857361-... | lld:pubmed |
| pubmed-article:2857361 | pubmed:meshHeading | pubmed-meshheading:2857361-... | lld:pubmed |
| pubmed-article:2857361 | pubmed:meshHeading | pubmed-meshheading:2857361-... | lld:pubmed |
| pubmed-article:2857361 | pubmed:meshHeading | pubmed-meshheading:2857361-... | lld:pubmed |
| pubmed-article:2857361 | pubmed:meshHeading | pubmed-meshheading:2857361-... | lld:pubmed |
| pubmed-article:2857361 | pubmed:meshHeading | pubmed-meshheading:2857361-... | lld:pubmed |
| pubmed-article:2857361 | pubmed:meshHeading | pubmed-meshheading:2857361-... | lld:pubmed |
| pubmed-article:2857361 | pubmed:meshHeading | pubmed-meshheading:2857361-... | lld:pubmed |
| pubmed-article:2857361 | pubmed:meshHeading | pubmed-meshheading:2857361-... | lld:pubmed |
| pubmed-article:2857361 | pubmed:meshHeading | pubmed-meshheading:2857361-... | lld:pubmed |
| pubmed-article:2857361 | pubmed:meshHeading | pubmed-meshheading:2857361-... | lld:pubmed |
| pubmed-article:2857361 | pubmed:year | 1985 | lld:pubmed |
| pubmed-article:2857361 | pubmed:articleTitle | Hyperbaric oxygen and multiple sclerosis: short-term results of a placebo-controlled, double-blind trial. | lld:pubmed |
| pubmed-article:2857361 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2857361 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:2857361 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:2857361 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:2857361 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2857361 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2857361 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2857361 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2857361 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2857361 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2857361 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2857361 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2857361 | lld:pubmed |
